Purpose Invasive pulmonary aspergillosis has been increasingly recognized in COVID-19
patients, termed COVID-19-associate pulmonary aspergillosis (CAPA). Our meta-analysis …

Summary COVID-19-associated pulmonary aspergillosis (CAPA) is defined as invasive
pulmonary aspergillosis occurring in COVID-19 patients. The purpose of this review was to …

Background COVID-19-associated pulmonary aspergillosis (CAPA) has been reported to be
an emerging and potentially fatal complication of severe COVID-19. However, risk factors for …

In this systematic review, we investigate the epidemiology, pathogenesis, risk factors, clinical
manifestations, diagnosis and treatment of COVID-19-associated pulmonary aspergillosis …

Abstract COVID‐19‐associated pulmonary aspergillosis (CAPA) has been reported
worldwide. However, basic epidemiological characteristics have not been well established …

Background Pulmonary aspergillosis may complicate coronavirus disease 2019 (COVID-19)
and contribute to excess mortality in intensive care unit (ICU) patients. The disease is poorly …

Invasive Pulmonary Aspergillosis (IPA) has been recognized as a possible secondary
infection complicating Coronavirus disease 2019 (COVID-19) and increasing mortality. The …

Abstract Objectives Coronavirus disease 2019 (COVID-19)-associated pulmonary
aspergillosis (CAPA) has emerged as a complication in critically ill COVID-19 patients. The …

Abstract Background Coronavirus disease 2019 (COVID-19)–associated pulmonary
aspergillosis (CAPA) occurs in critically ill patients with COVID-19. Risks and outcomes …

Purpose Invasive pulmonary aspergillosis (IPA) is increasingly reported in patients with
severe coronavirus disease 2019 (COVID-19) admitted to the intensive care unit (ICU) …